As per reports, the Mankind Pharma latest GMP suggests a premium of Rs 120, suggesting that the scrip will have a remarkable debut on its stock market listing.
As per reports, the Mankind Pharma latest GMP suggests a premium of Rs 103, suggesting that the scrip will have a remarkable debut on its stock market listing.